| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mi | IWG launches $50 million share buyback program for 2026 | ||
| Mi | Tower Semiconductor stock rating downgraded by Wedbush on valuation | ||
| Mi | Freedom Capital Markets initiates Buy rating on International Bancshares stock | ||
| Mi | Praxis Precision Medicines stock gains as TD Cowen reiterates Buy on FDA breakthrough status | ||
| Mi | GlobalFoundries stock rating downgraded to Neutral by Wedbush | ||
| Mi | Profusa expands European footprint with French distributor partnership | ||
| Mi | Capstone extends revolving credit facility with Berkshire Bank | ||
| Mi | BMO Capital resumes WSP Global stock coverage with Outperform rating | ||
| Mi | MakeMyTrip stock rating reiterated at Overweight by Morgan Stanley | ||
| Mi | Morgan Stanley sees China's December PMI strength driven by exports and policy | ||
| Mi | H.C. Wainwright reiterates Buy rating on Bright Minds stock with $115 target | ||
| Mi | Raymond James reiterates Outperform rating on Inflarx stock at $9 target | ||
| Mi | Pharos Energy receives $20 million payment from Egypt's EGPC | ||
| Mi | Electric Guitar's half-year profit hits £0.9m following CVA debt clearance | ||
| Mi | Wizz Air creates new financial performance committee led by Broderick | ||
| Mi | FDA grants priority review for Axsome's Alzheimer's agitation drug | ||
| Mi | BioAtla secures $40 million for phase 3 cancer drug development | ||
| Mi | William Blair reiterates Outperform rating on Globant stock | ||
| Mi | Verastem stock steady as Mizuho reiterates Outperform rating | ||
| Mi | Guggenheim reiterates Buy rating on Nike stock, maintains $77 price target | ||
| Mi | Leerink Partners reiterates Outperform rating on XOMA stock at $45 target | ||
| Mi | FDA supports Axsome's NDA submission for narcolepsy drug AXS-12 | ||
| Mi | Orcadian Energy reports £884,906 loss for fiscal year 2025 | ||
| Mi | SBC Medical Group announces $50 million shelf registration, share buyback | ||
| Mi | DA Davidson raises Gold.com price target to $42 on silver pricing benefits |